|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500099553 |
|
最近更新日期: Date of Last Refreshed on: |
2025-03-25 16:38:03 |
|
注册时间: Date of Registration: |
2025-03-25 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
脊髓损伤患者上尿路损伤的机制研究 |
|
Public title: |
Research on the Mechanism of Upper Urinary Tract Injury in Patients with Spinal Cord Injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
脊髓损伤患者上尿路损伤的机制研究 |
|
Scientific title: |
Research on the Mechanism of Upper Urinary Tract Injury in Patients with Spinal Cord Injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张茜 |
研究负责人: |
张茜 |
|
Applicant: |
Qian Zhang |
Study leader: |
Qian Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 183 6969 5563 |
研究负责人电话: Study leader's telephone: |
+86 183 6969 5563 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhangqianweiyi@126.com |
研究负责人电子邮件: Study leader's E-mail: |
zhangqianweiyi@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山东省潍坊市奎文区虞河路2428号 |
研究负责人通讯地址: |
山东省潍坊市奎文区虞河路2428号 |
|
Applicant address: |
No. 2428 Yuhe Road, Kuiwen District, Weifang City, Shandong Province |
Study leader's address: |
No. 2428 Yuhe Road, Kuiwen District, Weifang City, Shandong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
山东第二医科大学附属医院 |
||
|
Applicant's institution: |
The Affiliated Hospital of Shandong Second Medical University |
||
|
研究负责人所在单位: |
山东第二医科大学附属医院 |
||
|
Affiliation of the Leader: |
The Affiliated Hospital of Shandong Second Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
SDSMU-2025-ky-100 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
山东第二医科大学附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Affiliated Hospital of Shandong Second Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-12 00:00:00 |
||
|
伦理委员会联系人: |
张志英 |
||
|
Contact Name of the ethic committee: |
Zhiying Zhang |
||
|
伦理委员会联系地址: |
山东省潍坊市奎文区虞河路2428号 |
||
|
Contact Address of the ethic committee: |
No. 2428 Yuhe Road, Kuiwen District, Weifang City, Shandong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 536 308 1125 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
山东第二医科大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Hospital of Shandong Second Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
山东省潍坊市奎文区虞河路2428号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 2428 Yuhe Road, Kuiwen District, Weifang City, Shandong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-raised funds |
||||||||||||||||||||||
|
Target disease: |
Upper urinary tract damage |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本文在前人研究的基础上,采用定性比较分析的方法证明上尿路损害的发生是多种风险因素共同作用的结果,且推导出男性创伤性骶上型脊髓损伤患者上尿路功能损害发生的多条“等效因果链”,并对核心风险因素进行干预,有效预防该类患者上尿路功能损害的发生,为临床诊疗工作提供新的思路。 |
||||||||||||||||||||||
|
Objectives of Study: |
On the basis of previous studies, this paper adopts the method of qualitative comparative analysis to prove that the occurrence of upper urinary tract damage is the result of the joint action of multiple risk factors, and deduces the multiple "equivalent causal chains" of the occurrence of upper urinary tract damage in male traumatic suprasacral spinal cord injury patients, and intervenes in the core risk factors to effectively prevent the occurrence of upper urinary tract damage in these patients, providing new ideas for clinical diagnosis and treatment. The results of this study indicate that there are several "equivalent causal chains" in male patients with traumatic suprasacral spinal cord injury, and the intervention of core risk factors can effectively prevent the occurrence of this type of patients' upper urinary tract function damage, which can provide new ideas for clinical diagnosis and treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
纳入标准:(1)创伤所致的骶上型脊髓损伤;(2)年龄18-70 岁的男性患者;(3)损伤后出现下尿路功能障碍;(4)具备完整的临床信息和检查资料(如尿常规、血生化、尿动力学、排尿性膀胱尿道造影、腰骶部平片等)。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria: (1) trauma-induced suprasacral spinal cord injury; (2) male patients aged 18-70 years; (3) lower urinary tract dysfunction after the injury; (4) complete clinical information and examination data (e.g., routine urinalysis, blood biochemistry, urodynamics, voiding cystourethrocystography, and lumbosacral plain radiographs) were available. |
||||||||||||||||||||||
|
排除标准: |
排除标准:(1)脊髓休克期;(2)认知障碍或者并发重要脏器损伤;(3)伴有其他影响膀胱和肾脏功能的疾病,如后尿道瓣膜、尿道狭窄、肾炎等。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria: (1) spinal shock stage; (2) cognitive impairment or concomitant important organ injury; (3) accompanied by other diseases affecting bladder and kidney function, such as posterior urethral valve, urethral stenosis, nephritis. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-04-01 00:00:00至 To 2027-04-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-04-01 00:00:00 至 To 2027-04-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
国家生物信息中心,https://ngdc.cncb.ac.cn/gsub/,论文发表后。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/) after publication |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
国家生物信息中心 https://ngdc.cncb.ac.cn/gsub/ |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/) |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |